Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Trial to Assess FOLFIRI+Aflibercept Efficacy in Patients With Oxaliplatin-pretreated Metastatic Colorectal Cancer With or Without ACE Polymorphisms
- Status
- COMPLETED
- Phase
- PHASE2
Sym004 in Metastatic Colorectal Cancer and ECD-EGFR Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Evaluation of PET-CT for Staging of Colorectal Lung Metastases
- Status
- COMPLETED
- Phase
- N/A
Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus Cetuximab
- Status
- COMPLETED
- Phase
- PHASE3
Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Correlation Between Circulating Tumour Markers Early Variations and Clinical Response in First Line Treatment of Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- NA
Donafenib for Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Special Combination of BBI608 and Pembrolizumab
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Chemotherapy-related Toxicity, Nutritional Status and Quality of Life
- Status
- UNKNOWN
- Phase
- NA
Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- N/A
Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC
- Status
- COMPLETED
- Phase
- PHASE2
Technical Optimization of Detection of KRAS, BRAF and NRAS Mutations on Tumor DNA Circulating in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- NA
Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study for Validation of Immunological Biomarkers in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- NA
A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Pemetrexed and Erlotinib for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Treatment Response With CHOI and RECIST Criteria and CT Texture Analysis in Patients With Metastatic Colorectal Cancer Treated With Regorafenib
- Status
- COMPLETED
- Phase
- PHASE2